WINTON GROUP Ltd Has $35.33 Million Position in Colgate-Palmolive (CL)

WINTON GROUP Ltd increased its position in shares of Colgate-Palmolive (NYSE:CL) by 162.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 476,623 shares of the company’s stock after acquiring an additional 295,217 shares during the period. Colgate-Palmolive makes up about 1.0% of WINTON GROUP Ltd’s holdings, making the stock its 12th biggest position. WINTON GROUP Ltd owned 0.05% of Colgate-Palmolive worth $35,332,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of CL. Pacer Advisors Inc. increased its holdings in shares of Colgate-Palmolive by 8.4% in the 2nd quarter. Pacer Advisors Inc. now owns 20,224 shares of the company’s stock worth $1,499,000 after buying an additional 1,566 shares during the last quarter. Alliancebernstein L.P. boosted its stake in shares of Colgate-Palmolive by 4.2% in the 1st quarter. Alliancebernstein L.P. now owns 1,899,356 shares of the company’s stock valued at $139,014,000 after purchasing an additional 77,414 shares in the last quarter. Israel Discount Bank of New York purchased a new stake in shares of Colgate-Palmolive in the 1st quarter valued at $1,349,000. Principal Financial Group Inc. boosted its stake in shares of Colgate-Palmolive by 0.6% in the 1st quarter. Principal Financial Group Inc. now owns 1,271,008 shares of the company’s stock valued at $93,025,000 after purchasing an additional 7,905 shares in the last quarter. Finally, Personal Capital Advisors Corp boosted its stake in shares of Colgate-Palmolive by 5.8% in the 2nd quarter. Personal Capital Advisors Corp now owns 394,028 shares of the company’s stock valued at $29,209,000 after purchasing an additional 21,456 shares in the last quarter. 72.96% of the stock is currently owned by institutional investors and hedge funds.

A number of equities research analysts have recently issued reports on the stock. Zacks Investment Research cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday, October 17th. KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research note on Monday, October 16th. SunTrust Banks raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their price objective for the company from $65.00 to $85.00 in a research note on Wednesday, October 11th. Societe Generale cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price objective for the company. in a research note on Wednesday, November 29th. They noted that the move was a valuation call. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and issued a $74.00 price objective on shares of Colgate-Palmolive in a research note on Sunday, October 8th. Two equities research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and four have issued a buy rating to the company. Colgate-Palmolive currently has an average rating of “Hold” and a consensus price target of $76.04.

Colgate-Palmolive (CL) opened at $73.32 on Monday. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. Colgate-Palmolive has a 1-year low of $63.43 and a 1-year high of $77.27. The company has a market cap of $64,382.68, a price-to-earnings ratio of 25.55, a price-to-earnings-growth ratio of 3.36 and a beta of 0.81.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, October 27th. The company reported $0.73 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The business had revenue of $3.97 billion during the quarter, compared to analyst estimates of $3.94 billion. During the same period in the prior year, the business earned $0.73 EPS. The company’s revenue for the quarter was up 2.8% on a year-over-year basis. sell-side analysts predict that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Monday, October 23rd were paid a $0.40 dividend. The ex-dividend date was Friday, October 20th. This represents a $1.60 annualized dividend and a dividend yield of 2.18%. Colgate-Palmolive’s payout ratio is 61.78%.

In related news, Director Stephen I. Sadove sold 20,780 shares of the stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $70.52, for a total value of $1,465,405.60. Following the completion of the transaction, the director now directly owns 36,268 shares in the company, valued at approximately $2,557,619.36. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Justin Skala sold 126,393 shares of the stock in a transaction dated Thursday, November 9th. The stock was sold at an average price of $72.97, for a total transaction of $9,222,897.21. Following the completion of the transaction, the chief operating officer now owns 262,361 shares of the company’s stock, valued at $19,144,482.17. The disclosure for this sale can be found here. Over the last quarter, insiders sold 173,673 shares of company stock valued at $12,629,293. 1.02% of the stock is owned by company insiders.

COPYRIGHT VIOLATION NOTICE: This news story was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this news story on another domain, it was illegally copied and reposted in violation of US & international trademark and copyright law. The legal version of this news story can be accessed at https://www.dispatchtribunal.com/2017/12/11/winton-group-ltd-has-35-33-million-position-in-colgate-palmolive-cl.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply